Zydus plans obesity jab launch in a novel pen device
Zydus has received regulatory approval from the Drug Controller General of India (DCGI) to market and manufacture semaglutide to treat type 2 diabetes and obesity.
**India’s Semiconductor Ecosystem Attracts Global Investment** India’s burgeoning semiconductor ecosystem is drawing significant interest from international players in related sectors,…
A dedicated blog writer with a passion for capturing the pulse of viral news, Vimal covers a diverse range of topics, including international and national affairs, business trends, cryptocurrency, and technological advancements. Known for delivering timely and compelling content, this writer brings a sharp perspective and a commitment to keeping readers informed and engaged.